NCT04767802Phase 2Completed

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

Study sponsor: Protagonist Therapeutics, Inc. · PTGX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-15Actual
Enrollment · participants20Actual
Source updated2024-03-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview